China

George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

George Clinical in China

Tweet about this on TwitterShare on FacebookShare on LinkedIn

China is George Clinical’s largest hub outside the head office of Sydney, offering full CRO services and a site network that spans the country.

With its immense potential for patient recruitment and a rapidly growing pharmaceutical market, China, currently the third largest in the world, is an obvious choice for many when entering the Asian market.

The Chinese healthcare delivery system consists of public hospitals and community healthcare centers, with an increasing private care system. Only GCP accredited sites are eligible for running commercial Phase I, II and III studies, and this accreditation can only be achieved by public hospitals in China. The accreditation is issued by the CFDA and NHPFC based upon a site inspection. Accreditation is renewed every 3 years, with a quality review performed by the PFDA every year.

George Clinical has an extensive network of over 260 trial centers in 50 cities for Phase II-IV trials, and a wider network that includes community health centers in semi-urban and rural areas for Phase IV trials.

What are the benefits of conducting clinical trials in China?

  • China has access to a large patient pool
  • Rapidly developing medical infrastructure in urban centres and centres of excellence for many common diseases such as hypertension, diabetes and renal disease
  • Low operational costs

What are the prevalent diseases in China?

  1. Stroke
  2. Ischaemic Heart Disease
  3. Chronic obstructive pulmonary disease
  4. Cancer
  5. Road injury
  6. Hypertension
  7. Diabetes mellitus
  8. Lower respiratory infections

George Clinical China News

乔治健康研究所食先知大获青睐

8月17-18日,乔治健康研究所携“食先知”创新营养应用软件,参加中国疾病预防控制中心主办的第六届中国健康生活方式大会,向参会观众推广健康生活方式的同时展示了食先知手机应用软件,帮助消费者进行更健康的食品选择。

FoodSwitch a hit at China's Healthy Lifestyle conference

On 17-18 August, Nutrition and Lifestyle researchers from The George Institute China (GI China) attended the sixth China Healthy Lifestyle conference, hosted by Chinese Centre for Disease Control and Prevention (China CDC), to introduce the FoodSwitch mobile app to the audie...

全生命周期妇女健康与发展研讨会在京召开

8月4日,由国家卫生计生委妇幼司、联合国人口基金驻华代表处共同主办,全国妇幼卫生监测办公室、乔治全球健康研究院(中国)承办的全生命周期妇女健康与发展研讨会在北京召开。国家卫生计生委妇幼司司长秦耕、副司长沈海屏、副巡视员曹彬,联合国人口基金驻华代表洪腾出席会议。

'Women’s health through life course and empowerment' symposium held in Beijing

On 4th August, China's Department of Maternal and Child Health of National Health and Family Planning Commission (Department of MCH, NHFPC) and United Nations Population Fund China Office (UNFPA China) held the symposium on "Women’s health through life course and empower...

卫生经济学和过程评价工作坊完美收官

2017年8月2日,卫生经济学和过程评价工作坊在北京乔治健康研究所圆满落幕。

Health economics and process evaluation training workshop held successfully at The George Institute, China

On August 2, a Health Economics and Process Evaluation training workshop was held at the offices of The George Institute, China.

Contact

George Clinical Address:
Level 18, Tower B, Horizon Tower
Haidian District
Beijing, 100088
P.R. China

2223, 22/F Tomson Commercial Building,
710 Dongfang Road, Pudong District
Shanghai, 200122
P.R. China

Details

Number of Personnel: 50
In-country Services:

Beijing
Project Management, Clinical Operations, Data Management, Medical and Safety Services, Clinical Compliance, Regulatory Services, Statistics, Health Economics

Shanghai
Clinical Operations

Chengdu
Clinical Operations

Harbin
Project Management, Clinical Operations

Population: 1.4 billion
Official Language: Putonghua (Mandarin). Local dialects may be used
Hospital Records Language: Simplified Chinese
Electronic Hospital Records: Currently, paper records are used.

Twitter Facebook LinkedIn